HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

soluflazine

nucleoside transport inhibitor; analog of mioflazine

Also Known As:

R 64719; R-64719; Soluflazine

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperazines: 26
    - soluflazine: 3

Experts

1.	Biermans, Maria: 1 article (01/2012)
2.	Hoffmann, Vincent Lh: 1 article (01/2012)
3.	Maes, Sabine S: 1 article (01/2012)
4.	Meert, Theo F: 1 article (01/2012)
5.	Pype, Stefan: 1 article (01/2012)

Related Diseases

1.	Hypoxia (Hypoxemia) 02/01/1993 - "During severe N2-induced hypoxia, soluflazine significantly delayed hypoxic depolarization. " 03/06/1989 - "Soluflazine, administered topically or systemically, failed to enhance adenosine release and did not consistently alter the hypoxia/ischemia-evoked releases of inosine, hypoxanthine and xanthine. "
2.	Ischemia 03/06/1989 - "Soluflazine, administered topically or systemically, failed to enhance adenosine release and did not consistently alter the hypoxia/ischemia-evoked releases of inosine, hypoxanthine and xanthine. "
3.	Hyperalgesia 01/01/2012 - "Draflazine, dipyridamole, dilazep, lidoflazine, soluflazine, and KF24345 showed efficacy in the CFA thermal hyperalgesia model. "

Related Drugs and Biologics

1.	Xanthine
2.	Hypoxanthine
3.	Lidoflazine
4.	Inosine
5.	Dipyridamole (Persantine)
6.	Dilazep
7.	Adenosine (Adenocard)
8.	3- (1- (6,7- diethoxy- 2- morpholinoquinazolin- 4- yl)piperidin- 4- yl)- 1,6- dimethyl- 2,4- (1H,3H)- quinazolinedione
9.	draflazine